secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2026-05-08T23:59:59+00:00
Accession:  0001099800-26-000028
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edwards shareholders approve 7M share increase in Long-Term Stock Program
-------------------------------------------------------------------------

- Stockholders authorized 7M additional shares, raising total available to 341.5M under the amended program.
- All 9 director nominees reelected; proposal received between 428M and 474M For votes each.
- Advisory vote on named executive officer compensation passed with ~89% of votes cast.
- Ratification of PwC as independent auditor for FY2026 approved with ~89% of votes cast.
- Stock program amendment (Proposal 4) passed with 456.7M For (96% of votes cast, excluding broker non-votes).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000109980026000028/0001099800-26-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000109980026000028/ew-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001099800-26-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer